08:00 , Dec 7, 2015 |  BC Week In Review  |  Company News

Amdipharm Mercury, Concordia Healthcare deal

Concordia completed its acquisition of fellow generic and pharmaceutical company Amdipharm from private equity firm Cinven for $3.1 billion, including $1.4 billion in debt. The acquisition consists of L800 million ($1.2 billion) in cash, $47.5...
07:00 , Oct 12, 2015 |  BC Week In Review  |  Company News

Amdipharm Mercury, Concordia Healthcare deal

Concordia will acquire fellow generic and pharmaceutical company Amdipharm from private equity firm Cinven for up to $3.6 billion, including debt. The acquisition consists of L800 million ($1.2 billion) in cash and 8.5 million of...
07:00 , Sep 28, 2015 |  BC Week In Review  |  Financial News

Concordia Healthcare completes follow-on

Concordia Healthcare Corp. (TSX:CXR; NASDAQ:CXRX), Oakville, Ontario   Business: Neurology, Inflammation, Cancer   Date completed: 2015-09-24   Type: Follow-on   Raised: $520 million   Shares: 8 million   Price: $65   Shares after offering: 42.3...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Company News

Lansen Pharmaceutical, Novartis deal

Lansen acquired Chinese rights to the Sicorten Plus brand from Novartis for $8 million up front. Lansen said it also acquired the Swiss Marketing Authorization, know-how, books and records, specified trademarks and commercial and medical...